paclitaxel has been researched along with Multiple Sclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Argyriou, AA; Bruna, J; Cavaletti, G; Ferrari, S; Kalofonos, HP; Kalofonou, F; Karteri, S; Mariotto, S; Simo, M; Velissaris, D | 1 |
| La Flamme, AC; Miller, JH; Northcote, PT; O'Sullivan, D | 1 |
| Harauz, G; Musse, AA; Polverini, E; Raijmakers, R | 1 |
| Crume, KP; La Flamme, AC; Miller, JH; Northcote, PT; O'Sullivan, D | 1 |
| Cao, L; Cruz, T; Ludwin, SK; Moscarello, MA; Sun, D; Whitaker, JN | 1 |
| Ludwin, SK; Mak, B; Mastronardi, F; Moscarello, MA; Nguyen, TA; Wood, DD | 1 |
6 other study(ies) available for paclitaxel and Multiple Sclerosis
| Article | Year |
|---|---|
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study.
Topics: Aged; Biomarkers; Breast Neoplasms; Cognitive Dysfunction; Female; Humans; Intermediate Filaments; Middle Aged; Multiple Sclerosis; Paclitaxel; Prospective Studies | 2022 |
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bridged Bicyclo Compounds, Heterocyclic; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Disease Progression; Docetaxel; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Epothilones; Growth Inhibitors; Humans; Lactones; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microtubules; Multiple Sclerosis; Paclitaxel; Taxoids | 2013 |
Kinetics of human peptidylarginine deiminase 2 (hPAD2)--reduction of Ca2+ dependence by phospholipids and assessment of proposed inhibition by paclitaxel side chains.
Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Calcium; Catalytic Domain; Humans; Hydrolases; Isoenzymes; Kinetics; Models, Molecular; Molecular Sequence Data; Molecular Structure; Multiple Sclerosis; Paclitaxel; Phospholipids; Protein Conformation; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Sequence Alignment | 2008 |
Delaying the onset of experimental autoimmune encephalomyelitis with the microtubule-stabilizing compounds, paclitaxel and Peloruside A.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Encephalomyelitis, Autoimmune, Experimental; Female; G2 Phase; Lactones; Macrophages; Mice; Mice, Inbred BALB C; Microtubules; Multiple Sclerosis; Paclitaxel; T-Lymphocytes; Time Factors; Tubulin Modulators | 2009 |
Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel.
Topics: Amino Acid Sequence; Animals; Antigens; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Guinea Pigs; Immunization, Passive; Inflammation; Lymphocyte Activation; Micelles; Molecular Sequence Data; Multiple Sclerosis; Myelin Basic Protein; Paclitaxel; Paralysis; Peptide Fragments; Rats; Rats, Inbred Lew; T-Lymphocytes; Weight Loss | 2000 |
Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination.
Topics: Animals; Astrocytes; Biomarkers; Brain; Cell Division; Cell Nucleus; Cerebellum; Drug Evaluation, Preclinical; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Gliosis; Hereditary Central Nervous System Demyelinating Diseases; Injections, Intraperitoneal; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Multiple Sclerosis; Myelin Proteins; Myelin Proteolipid Protein; Myelin Sheath; Nerve Tissue Proteins; Nervous System Autoimmune Disease, Experimental; Oligodendroglia; Paclitaxel; Signal Transduction | 2002 |